Important note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.
Important note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.
Reuters NewMedia, Inc. - Wednesday, 4 December 1996.
"This business is literally exploding at this point in time," Edward Penhoet, Chiron's chief executive, told a Robertson Stephens Medical Conference.
He said end-user sales of Chiron's viral load tests would approach $100 million in 1996. He did not give a comparative figure.
Chiron and Roche Holding Ltd ROCZg.S makes sophisticated tests of viral loads that can provide an indication of how likely an HIV infected patient will progress to AIDS, how effective anti-viral drugs are working and early warning against drug resistance.
Penhoet said total potential annual sales for the tests could be over $200 million for HIV, $150 million for the hepatitis C virus and $50 million for hepatitis B virus.
The market is now shared equally by Chiron and Roche, he said.
Penhoet expected use of the tests to expand beyond infectious disease to be used in monitoring genetically-based diseases.
-- New York Newsdesk 212-859-1610.
961204
RE961219
Copyright © 1996 - Reuters, Ltd. All rights reserved. Republication or redistribution of Reuters content is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Contact Reuters.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 1996. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 1996. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .